Breaking News

MilliporeSigma Expands Excipients Portfolio

Adding Polymers for Sustained Release Injectables

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

MilliporeSigma has entered into an agreement with PCAS S.A. of Longjumeau, France to be the exclusive, global distributorof PCAS’Expansorb line of biocompatible and biodegradable polymers.   The portfolio will include 38 polymers for sustained release of small molecule and selected peptide injectables, allowing customers to optimize and control release kinetics of final drug products. The ability to better control and sustain the release of drugs allows for delivery via reduced numbers of inje...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters